VEGFA and neoplasm: Mice with LLC exhibited a 15% increase in plasma concentration of VEGF (p < 0.01, Figure 5a) and a 28% increase in TIMP-1 (p = 0.01, Figure 5b) compared to non-tumor-bearing controls.